Heliogen, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization
Impairment charges
Provision for inventory reserve
Share-based compensation
Loss on remeasurement of SAFE instruments
Change in fair value of warrants
Provision for contract losses
Change in fair value of contingent consideration
Deferred income taxes
Non-cash operating lease expense
Other non-cash operating activities
Changes in assets and liabilities:
Receivables, net
Inventories, net
Prepaid and other current assets
Other long-term assets
Trade payables
Trade payables and accrued liabilities
Contract liabilities
Change in contract loss provisions, net
Accrued expenses and other current liabilities
Operating lease liabilities
Other long-term liabilities
Other non-current assets and liabilities
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures
Proceeds from sale of property, plant and equipment
Purchases of available-for-sale securities
Maturities of available-for-sale securities
Sales of available-for-sale securities
Acquisition of HelioHeat, net of cash acquired
Other investing activities
Net cash provided by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from preferred shares, net of issuance costs of $13.3 thousand
Proceeds from SAFE instruments, net of issuance costs of $30
Proceeds from Paycheck Protection Program loan
Repayments on Paycheck Protection Program loan
Proceeds from exercise of stock options
Proceeds from exercise of warrants
Proceeds from issuance of common stock under employee stock purchase plan
Payment related to taxes for net-share settlement of share-based compensation
Payment for fractional shares in connection with the reverse stock split
Other financing costs
Net cash provided by (used in) financing activities

Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Cash paid for interest
Cash paid for amounts included in the measurement of operating lease liabilities
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for new operating lease liabilities
Right-of-use asset removed upon lease termination
Fair value of Project Warrants recognized in equity
Contingent consideration
Net working capital assumed as part of the Business Combination
Capital expenditures incurred but not yet paid
Non-cash settlement of note receivable
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Short-term restricted cash
Long-term restricted cash

Comments